DRREDDY's weekly performance was disappointing, with a return of -1.84%, underperforming its peers. The stock's volatility was relatively low at 6.7%, but its Sharpe Ratio of -1.10 indicates poor risk-adjusted returns. Compared to its peers, DRREDDY underperformed SUNPHARMA and was on par with HINDUNILVR, but outperformed DIVISLAB. Overall, the stock was relatively less risky this week, but its negative returns and poor Sharpe Ratio suggest caution.

[Volatility: 6.7%]